These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28651012)

  • 1. The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C
    PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status.
    Mpunga T; Chantal Umulisa M; Tenet V; Rugwizangoga B; Milner DA; Munyanshongore C; Heideman DAM; Bleeker MCG; Tommasino M; Franceschi S; Baussano I; Gheit T; Sayinzoga F; Clifford GM
    Int J Cancer; 2020 Mar; 146(6):1514-1522. PubMed ID: 31173641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Productivity costs due to human papillomavirus-related cancer mortality in the United Kingdom.
    Engelbrecht K; Ovcinnikova O; Ntais D; Shoel H; Meiwald A; Hughes R; Weston G; Morais E; Bencina G
    J Med Econ; 2024 Apr; 27(sup2):20-29. PubMed ID: 38889319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs.
    Sabale U; Karamousouli E; Popovic L; Krasznai ZT; Harrop D; Meiwald A; Hughes R; Weston G; Bencina G
    J Med Econ; 2024 Apr; 27(sup2):1-8. PubMed ID: 38638098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden and indirect cost of vaccine-preventable cancer mortality in Europe.
    Bencina G; Sabale U; Morais E; Ovcinnikova O; Oliver E; Shoel H; Meiwald A; Hughes R; Weston G; Sundström K
    J Med Econ; 2024 Apr; 27(sup2):30-40. PubMed ID: 39010684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of human papillomavirus-related diseases in Italy.
    Baio G; Capone A; Marcellusi A; Mennini FS; Favato G
    PLoS One; 2012; 7(11):e49699. PubMed ID: 23185412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer incidence in Germany attributable to human papillomavirus in 2013.
    Buttmann-Schweiger N; Deleré Y; Klug SJ; Kraywinkel K
    BMC Cancer; 2017 Oct; 17(1):682. PubMed ID: 29037233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States.
    Wu CF; Xu L; Fu S; Peng HL; Messick CA; Lairson DR
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1156-1164. PubMed ID: 30362917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalizations associated with malignant neoplasia and in situ carcinoma in the anus and penis in men and women during a 5-year period (2009-2013) in Spain: An epidemiological study.
    López N; Gil-de-Miguel Á; Pascual-García R; Gil-Prieto R
    Hum Vaccin Immunother; 2017 Oct; 13(10):2292-2299. PubMed ID: 28708948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Estimated Lifetime Medical Cost of Diseases Attributable to Human Papillomavirus Infections Acquired in 2018.
    Chesson HW; Laprise JF; Brisson M; Martin D; Ekwueme DU; Markowitz LE
    Sex Transm Dis; 2021 Apr; 48(4):278-284. PubMed ID: 33492104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    de Martel C; Plummer M; Vignat J; Franceschi S
    Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.
    Giuliano AR; Nyitray AG; Kreimer AR; Pierce Campbell CM; Goodman MT; Sudenga SL; Monsonego J; Franceschi S
    Int J Cancer; 2015 Jun; 136(12):2752-60. PubMed ID: 25043222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre.
    Hampl M; Huppertz E; Schulz-Holstege O; Kok P; Schmitter S
    BMC Infect Dis; 2011 Mar; 11():73. PubMed ID: 21426562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Grade Vulvar, Vaginal, and Anal Precancers Among U.S. Adolescents and Young Adults After Human Papillomavirus Vaccine Introduction.
    Mix JM; Saraiya M; Senkomago V; Unger ER
    Am J Prev Med; 2022 Jan; 62(1):95-99. PubMed ID: 34922655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of HPV associated cancers in two regions in Nigeria 2012-2014.
    Jedy-Agba EE; Dareng EO; Adebamowo SN; Odutola M; Oga EA; Igbinoba F; Otu T; Ezeome E; Bray F; Hassan R; Adebamowo CA
    Cancer Epidemiol; 2016 Dec; 45():91-97. PubMed ID: 27780076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China.
    Duan R; Qiao Y; Clifford G; Zhao F
    Cancer Med; 2020 Jan; 9(1):374-384. PubMed ID: 31714036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life valuations of HPV-associated cancer health states by the general population.
    Conway EL; Farmer KC; Lynch WJ; Rees GL; Wain G; Adams J
    Sex Transm Infect; 2012 Nov; 88(7):517-21. PubMed ID: 22645393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States.
    Clay PA; Thompson TD; Markowitz LE; Ekwueme DU; Saraiya M; Chesson HW
    Vaccine; 2023 Mar; 41(14):2376-2381. PubMed ID: 36907737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Human Papillomavirus (HPV) DNA among Men with Oropharyngeal and Anogenital Cancers: A Systematic Review and Meta-Analysis.
    Sasidharanpillai S; Ravishankar N; Kamath V; Bhat PV; Bhatt P; Arunkumar G
    Asian Pac J Cancer Prev; 2021 May; 22(5):1351-1364. PubMed ID: 34048162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess Cancer Cases and Medical Costs Due to Suboptimal Human Papillomavirus Vaccination Coverage in California.
    Baughan EB; Keizur EM; Damico CA; Arnold EM; Ko JS; Klausner JD
    Sex Transm Dis; 2019 Aug; 46(8):527-531. PubMed ID: 31295221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.